Mazagon Dock A Government Undertaking Shipbuilding Navratna Company with market valuation of 130,868 Crore, Established in 1960 , Till date delivered 805 Vessel, 30 Warships & 8 submarines National & International Clients, MDL also delivered cargo ship, passengers ship, water tankers, tugs dredgers , barges, wellhead platform decks & process platform etc.

Yes Bank is seeing improvement in its NPA and an increase in profits.

Read more stock news on equitybsense.blogspot.com

Stock Surge 60% in Last Six Month

Stock price surged 60% in last 20 weeks , In Feb stock was trading at ₹ 2131 and reached to ₹ 3775 in May, delivered a robust growth, Stock split in 1:2 Ratio. Stock has a new face value of ₹ 5 , if anyone having 10 share , he will get 10 more share, total share now will be 20 Numbers.

Mazagon Deck Acquire Colombo Dockyard

The acquistion process will going to complete within four to six month and the value of acquistion will not exceed $52.96 mn, this includes the primary & secondary , upon completing formalities the Mazagaon Dock will have controlling stake with equity holding of 51% stake & Mazagaon will take control of CDPLC and this became subsidiary of Mazagaon Ship Building.

Mazagon stated that the proposed acquisition is aimed at strengthening its foothold in the ship repair and shipbuilding sectors by leveraging operational synergies, enhancing R&D capabilities, and expanding market presence in line with its long-term growth strategy. According to the DFC( Development Finance Corporation ), the port is the largest and busiest transshipment hub in the Indian Ocean and has been operating at over 90% capacity since 2021, highlighting the need for an additional terminal to meet growing demand.

the article reference taken from the ship technology

Shareholding of Mazagaon Dock

Dec 2024 & March 2025

Promoter Stake 83.83% 84.83%

FII Stake 1.55% 2.26%

DII Stake 1.47% 1.7%

Public Stake 10.48% 9.56%

Financials March 2024 Vs March 2025

Total Sales ₹3103 Cr. ₹3174 Cr.

Total Profit ₹654 Cr. ₹326 Cr.

Conclusion

With the acquisition expected to be completed in the next 4 to 6 months, control over business and operations will open new global avenues and unlock greater business opportunities. This is anticipated to enhance both the company’s valuation and overall worth in the future.

Mazagaon Dock

Mazagoan dock is the only company of INDIA which is so much diversified and has the Client of India and Global Ample.

Disclaimer

The content shared on Marketbarrister is for informational and educational purposes only. All articles, analysis, charts, opinions, and insights reflect personal views and interpretations based on self-study, publicly available information, and market trends.
We are not SEBI-registered advisors, and none of the content on this blog should be considered as investment, trading, legal, or financial advice. Readers are strongly advised to do their own research or consult with a certified financial advisor before making any investment decisions.
While we strive to provide accurate and timely information, Marketbarrister does not guarantee the completeness, reliability, or accuracy of any data or views shared. Markets are subject to risk, and past performance is not indicative of future results.
By using this blog, you acknowledge and agree that Marketbarrister  and its contributors are not liable for any loss or damage arising from the use of the content.

Stock fall from INR 1639 to INR 726 and now Trading 20 percent above its lowest in 90 days with strong volume

Thanks

Natco Pharma 52 Week Week High ₹ 1639

Natco Pharma 52 Week Week Low ₹ 726

Why Natco Pharma Declined ?

The Company declined from the Highest of ₹ 1639 to ₹ 726 in previous , However the stock is declining from the Sep-2024 due to the global uncertanity but the stock dropped heavily in December post Q3Y25.

The decline was primarily due to a sharp drop in export formulation sales, which fell from ₹605 crore in Dec-23 to ₹286 crore in Dec-24—a 53% decrease. This was largely driven by a significant reduction in Revlimid sales, the company’s main revenue contributor, which had a substantial impact on overall financial performance.

Read More on Market Barrister

EaseMyTrip is the 2nd largest Online Travel Platform in India founded in 2008

Gensol Engineering Collapse from 1376 to 116 in 14 Month

Natco Pharma Q4FY2025 Strong Performance

Natco Pharma’s Q4 FY2025 financial results have shown strong performance. The stock has also recorded a notable improvement compared to Q3 FY2025.

Total sales for Q4 FY2025 stood at ₹1,221 crore, compared to ₹1,068 crore in the same quarter last year, marking a solid year-on-year growth. Notably, the company reported a remarkable 200+% increase in Profit After Tax (PAT), reaching ₹406 crore in Q4 FY2025, up from ₹132 crore in Q3 FY2025.

About Natco Pharma 

Natco Pharma Limited is a vertically integrated and innovation-led pharmaceutical company engaged in the development, manufacturing, and marketing of Finished Dosage Formulations (FDF) and Active Pharmaceutical Ingredients (APIs). With a strong focus on niche therapies and complex generics, Natco has established a presence in over 50 countries.

The company markets its FDF products across key regions including the United States, India, Europe, and other international markets, and operates in select geographies through its subsidiaries. Natco has built a strong reputation as a reliable, high-quality manufacturer of niche Active Pharmaceutical Ingredients (APIs), with a track record of producing over 50 APIs. While oncology remains our primary therapeutic focus,  broadening our portfolio to include products in Central Nervous System (CNS) disorders, pain management, and cardiovascular care. Natco consistently creates first-to-market opportunities for its partners and customers.

Natco Pharma on Monthly  Chart

The chart looks attractive on monthly basis, However after making a low of  ₹ 757 the stock gain the break out in the upward direction with the strong volume , Stock has gained the momentum of 20% in last three months and performing good on NSE & BSE.

Natco Pharma Delivers Strong Annual Performance with Exceptional Quarterly Surge

Over the past year, Natco Pharma has consistently delivered strong performance and maintained healthy profitability. In the most recent quarter, the company recorded a remarkable increase in sales, accompanied by a sharp surge in Profit After Tax (PAT). This robust financial performance is further reinforced by a significant rise in trading volumes on the monthly charts, reflecting strong market confidence.

Disclaimer

The information provided on this website is for educational and informational purposes only and should not be considered as financial, investment, or trading advice. All content, including stock analyses, market data, and opinions, is based on publicly available information believed to be accurate at the time of publication.

TATA POWER

DEFENCE SECTOR 

Vedanta Demerger in five Verticals-Promoters stake 100% Pledge & Q3Y24 Result

Q4 Profits Jumps FIVE Folds, Stock Price Soars doubles from April 2024 to May 2025, Company’s Operation Revenue grows to 10851 Crore

Suzlon energy has delivered the tremendous growth in this Q4,2025 and has delivered 5 times growth profit  compare to the Q4,2024

Operational revenue increased significantly from ₹6,496 crore in March 2024 to ₹10,861 crore in March 2025, reflecting a robust growth of 70%

The stock price has surged from ₹35 to ₹72 over the past year, with further growth anticipated in the future

Suzlon highlighted that the installed capacity as of March 2025 stands at 475 GW. The projected target is 777 GW by 2030 and 2,100 GW by the year 2047 including wind, power, solar ,hydro also whereas the major part comes from the SOLAR projects.

Market Cap ₹ 97,742 Cr.

PE: 46.7

ROCE: 32.4 %

52W low: ₹44.30

52W high: ₹86.04

Currently, the stock is trading on NSE ,BSE at  ₹71.48, Stock reached highest in September 2024  ₹ 86 .04

Suzlon Energy Reports Strong Growth with Robust Order Book and Financial Performance

Suzlon Energy continues to strengthen its position in the renewable energy sector, maintaining a robust order book across both solar and wind energy segments. The company recently secured significant wind energy orders including:

• 100.8 MW from Sunsure Energy

• 378.0 MW from NTPC Green Energy

• 50.4 MW from Bharat Petroleum Corporation Limited (BPCL)

As of May 2025, Suzlon’s total wind energy order book stands at an impressive 5,555 MW, with several additional projects currently in the pipeline.

On the financial front, Suzlon has demonstrated substantial year-on-year (YoY) growth:

• Revenue rose from ₹2,179 crore in Q4 FY24 to ₹3,774 crore in Q4 FY25, reflecting a 73% YoY increase.

• Profit After Tax (PAT) surged from ₹281 crore in Q4 FY24 to ₹1,181 crore in Q4 FY25, marking a remarkable 320% YoY growth.

• EBITDA for Q4 FY25 stood at ₹693 crore, contributing to a full-year EBITDA of ₹1,857 crore.

These results underscore Suzlon Energy’s strong operational performance and its growing role in India’s transition to sustainable energy.

Suzlon has shown the good number and the Company execution has good execution strategy and the growth showing the good number QoQ, with 30% cumulative market share and the provides the best in class of maintenance services for their customer.

GoI vision of to complete the 500 Gwatt by 2030 , This shows that Government of India has started work on developing energy corridor not today but the work started in the year of 2015  itself, Since than work has started on war front basis and many project were delivered across many states of India and yet more progress to be achieved in next years.

Suzlon Windies Energy States of India

• Rajasthan                   2.3GW
• Gujarat                       4.2GW
• Maharashtra              2.2GW
• Karnataka                  1.3GW
• Kerala                        0.03GW
• Madhya Pradesh       0.05GW
• Telangana                 0 .01GW
• Andhra Pradesh       1.6GW
• Tamil Nadu               2.8GW

Suzlon Energy India Leaders in Service and Maintenance

Suzlon Energy is recognized as India’s leading company in wind Operations & Maintenance (O&M), backed by a structured escalation clause of 4–5% in service fees. With a strong growth trajectory and a rapidly expanding order book, Suzlon is well-positioned to emerge as the undisputed leader in the wind energy sector. The company’s robust performance and future pipeline underscore its dominant role in driving India’s wind-based renewable energy landscape.

Market Barrister

Why Gensol Engineering Company Stock Price falling from its high of INR 1376 

Natco Pharma declined from its lifetime high of  INR 1639 to INR 726. 

Conclusion

More growth yet to happen in all the sectors of :Manufacturing Metal and Mines, EPC ,Design and Consultancy Services and Indian economy is on the verge of next era.

Booming Stock ,High Revenue Sector for Next Five Years, GREEN Vision ,Green Energy ,Hydrogen Energy ,Solar Energy ,Bio Energy

Disclaimer

The information provided on this website is for educational and informational purposes only and should not be considered as financial, investment, or trading advice. All content, including stock analyses, market data, and opinions, is based on publicly available information believed to be accurate at the time of publication.

https://marketbarrister.com